WASHINGTON —

Lawmakers say middlemen in the prescription drug pipeline are limiting access to medications and driving up costs.

See the story in the video above Advertisement

It’s gotten the attention of both sides of the aisle and President Donald Trump, but reforms are stalled in Congress.

Patient advocacy groups representing a range of conditions, from cancer to arthritis to epilepsy, are calling for urgent action to rein in pharmacy benefit managers.

So is Jeremy Olimb. His sons are living with cystic fibrosis, a rare genetic disorder with a daunting regimen.

"Just seeing young children with handfuls of pills that they have to take in order to survive is a pretty bracing experience for most people," Olimb said.

It's a harsh reality that Olimb says was made more difficult by t

See Full Page